THE PLASMA HALOPERIDOL AND REDUCED HALOPERIDOL CONCENTRATIONS IN CHINESE SCHIZOPHRENIC-PATIENTS - RELATIONSHIP BETWEEN REDUCED HALOPERIDOL HALOPERIDOL RATIO AND RED-BLOOD-CELL HALOPERIDOL REDUCTASE-ACTIVITY

被引:3
作者
WONG, BYM
CHAN, MY
WONG, MTH
LIEHMAK, F
机构
[1] UNIV HONG KONG,FAC MED,DEPT PHARMACOL,HONG KONG,HONG KONG
[2] UNIV HONG KONG,FAC MED,DEPT PSYCHIAT,HONG KONG,HONG KONG
关键词
HALOPERIDOL; REDUCED HALOPERIDOL; SCHIZOPHRENIC;
D O I
10.1002/hup.470070207
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Fifteen chinese schizophrenic patients were given titrated doses of haloperidol (0.05-0.42 mg/kg) for two weeks. All these 15 patients were in clinical remission on maintenance dose of haloperidol. The mean plasma haloperidol and reduced haloperidol concentrations were 16.8 +/- 4.8 ng/ml and 13.6 +/- 5.7 ng/ml respectively. The plasma RHAL/HAL ratio was in the range of 0.13-1.94. These valueS were similar to that reported for the Japanese population. The frequency distribution appeared to be bimodal. RBC reductase activity were found to be distributed normally and no correlation was found between plasma RHAL/HAL ratio and RBC reductase activity.
引用
收藏
页码:123 / 128
页数:6
相关论文
共 19 条
[1]  
ALTAMURA AC, 1988, PROG NEUROPSYCHOPHAR, V12, P689
[2]   CUMULATIVE FREQUENCY CURVES IN POPULATION ANALYSIS [J].
BARLOW, R .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (10) :404-406
[3]  
CHAKRABORTY BS, 1989, EUR J CLIN PHARMACOL, V37, P45
[4]  
CHANG WH, 1987, BIOL PSYCHIAT, V22, P1406
[5]  
CHANG WH, 1989, BIOL PSYCHIAT, V26, P239
[6]  
ERESHEFSKY L, 1984, J CLIN PSYCHOPHARM, V4, P138
[7]  
FORSMAN A, 1978, CURR THER RES CLIN E, V24, P567
[8]  
FORSMAN AO, 1976, P ROY SOC MED, V69, P9
[9]   HALOPERIDOL REDUCTION CAN BE ASSAYED IN HUMAN RED-BLOOD-CELLS [J].
INABA, T ;
KALOW, W ;
SOMEYA, T ;
TAKAHASHI, S ;
CHEUNG, SW ;
TANG, SW .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1989, 67 (11) :1468-1469
[10]   REVERSIBLE METABOLISM OF HALOPERIDOL AND REDUCED HALOPERIDOL IN CHINESE SCHIZOPHRENIC-PATIENTS [J].
JANN, MW ;
LAM, YWF ;
CHANG, WH .
PSYCHOPHARMACOLOGY, 1990, 101 (01) :107-111